View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Deals Analysis
August 4, 2022

Asia-Pacific’s medical devices industry saw a drop of 26.05% in cross border deal activity in Q2 2022

By Carmen

Led by $230m acquisition of M.I.Tech, Asia-Pacific’s medical devices industry saw a drop of 26.05% in cross border deal activity during Q2 2022, when compared to the last four-quarter average, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.


A total of 22 cross border deals worth $689.9m were announced for the region during Q2 2022, against the last four-quarter average of 29.75 deals.

Of all the deal types, venture financing saw most activity in Q2 2022 with 13 deals, representing a 59.1% share for the region.

In second place was M&A with seven deals, followed by private equity deals with two transactions, respectively capturing a 31.8% and 9.1% share of the overall cross border deal activity for the quarter.

In terms of value of cross border deals, venture financing was the leading category in Asia-Pacific’s medical devices industry with $251.77m, while M&A and private equity deals totalled $230m and $208.13m, respectively.

Asia-Pacific medical devices industry cross border deals in Q2 2022: Top deals

The top five medical devices cross border deals accounted for an 82.5% share of the overall value during Q2 2022.

The combined value of the top five cross border deals stood at $569.13m, against the overall value of $689.9m recorded for the quarter.

1) Boston Scientific $230m acquisition deal for 64% stake in M.I.Tech

2) The $140.13m private equity of Genea by Liverpool Partners

3) Globis Capital Partners &,Incubate Fund,SoftBank Vision Fund 2 and World Innovation Lab (WiL fund) $70m venture financing deal with AI Medical Service

4) The $68m private equity of Accumax Lab Technology by Creador Sdn and India Life Sciences Fund III

5) Alkemi Venture Partners,Chiratae Ventures,HealthQuad,LC Nueva AIF,LeapFrog Investments,Schroders and Spark Growth Ventures $61m venture financing deal with Redcliffe Lifetech

Related Companies

Verdict deals analysis methodology

This analysis considers only announced and completed cross border deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

Topics in this article: ,
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Medical Device Network